Other Income & Expense
Other Income (Expense)
Incyte Other Income (Expense) decreased by 51.0% to $2.77M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 65.7%, from $8.10M to $2.77M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 33.1% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026Apr 28, 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.39M | $1.95M | $5.72M | $1.26M | $522.00K | $11.51M | -$13.81M | $32.87M | $42.67M | $46.37M | -$2.03M | $8.29M | $4.93M | $1.61M | $8.10M | $7.31M | $4.04M | $5.66M | $2.77M |
| QoQ Change | — | -55.6% | +193.4% | -78.0% | -58.6% | >999% | -220.0% | +338.0% | +29.8% | +8.7% | -104.4% | +509.3% | -40.6% | -67.3% | +401.9% | -9.7% | -44.7% | +40.1% | -51.0% |
| YoY Change | — | — | — | — | -88.1% | +491.0% | -341.7% | >999% | >999% | +302.8% | -106.2% | -80.6% | -89.4% | — | +499.6% | -11.9% | -18.0% | +251.1% | -65.7% |
Range-$13.81M – $46.37M
CAGR-9.7%
Avg YoY Growth+809.0%
Median YoY Growth-14.9%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Incyte's other income (expense)?
- Incyte (INCY) reported other income (expense) of $2.77M in Q1 2026.
- How has Incyte's other income (expense) changed year-over-year?
- Incyte's other income (expense) decreased by 65.7% year-over-year, from $8.10M to $2.77M.
- What is the long-term trend for Incyte's other income (expense)?
- Over 3 years (2021 to 2025), Incyte's other income (expense) has grown at a 33.1% compound annual growth rate (CAGR), from $10.65M to $25.11M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.